학술논문
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Document Type
Article
Author
Chavez, Julio C; Grajales, Ariel; Sandoval-Sus, Jose; Turba, Elyce; Nodzon, Lisa; Uriepero-Palma, Angimar; Ammad-Ud-Din, Mohammad; Sahakian, Eva; Komrokji, Rami; Sokol, Lubomir; Locke, Frederick L; Shah, Bijal; Lancet, Jeffrey; Sotomayor, Eduardo M; Kharfan-Dabaja, Mohamed A.; Bello, Celeste; Pinilla-Ibarz, Javier
Source
In Clinical Lymphoma, Myeloma and Leukemia June 2024 24(6):382-391
Subject
Language
ISSN
2152-2650